Your weekly roundup of the latest news from Drug Topics®.
Significant differences in the use of insulin pump and/or CGM technology were noted based on demographic and socioeconomic factors
The test is intended to complement the company’s TBI plasma test, which received FDA clearance in 2021.
Voxzogo is already available for patients over 5 years with a genetic cause of dwarfism. The PDUFA date is set for Oct. 21, 2023, and will potentially expand the drug to children 5 and under.
The drug, manufactured by Sandoz, will treat conditions including osteoporosis in postmenopausal women
The role of the pharmacy technician has evolved over the past 45 years—but pay hasn’t caught up
Podcast: Discussing the Shared Central Fulfillment Solution with iA
May 6th 2024Brian Nowosielski, associate editor with Drug Topics, sat down with Tom Utech and Reed Richardson of iA, an innovative pharmacy fulfillment company. Utech, CEO of iA, and Richardson, Chief Commercial Officer of iA, discussed the company's new shared central fulfillment solution. The new solution, designed to streamline processes within the pharmacy, is a technological innovation with life-saving benefits for patients.